Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CORCEPT THERAPEUTICS INC Financial Overview

  • Income Statement: CORT

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 209,000.00 482,000.00 -273,000.00 -130.62%
    Gross Profit 197,000.00 469,000.00 -272,000.00 -138.07%
    Net Income Before Extra Items/Preferred Div -20.06 M -11.57 M -8.49 M 42.31%
    Operating Income -19.69 M -12.24 M -7.44 M 37.81%
  • Cash Flow: CORT

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 19.32 M 18.87 M 445,000.00 2.30%
    Net Cash Flow - Investing -2.33 M 5.38 M -7.71 M 331.00%
    Net Cash Flow/Operating Activities -18.36 M -10.96 M -7.40 M 40.29%
  • Balance Sheet: CORT

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 25.88 M 17.85 M 8.02 M 31.01%
    Total Liabilities 2.87 M 3.01 M -142,000.00 -4.95%
    Shareholders Equity 23.01 M 14.84 M 8.17 M 35.50%
  • Key Ratios / Statistics: CORT

    • Valuation

      Price/Earnings (TTM) -2.37
      Price/Sales (TTM) 228.19
      Price/Book (MRQ) 2.97
      Price/Cash Flow (TTM) -5.94
    • Profitability

      Gross Margin 94.26
      Operating Margin -9,420.57
      Profit Margin -9,598.56
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 6.40
      Current Ratio (MRQ) 7.21
      Long Term Debt-to-Equity (MRQ) 0.01
    • Management Effectiveness

      Return on Equity (TTM) -103.01
      Return on Assets (TTM) -91.76
      Return on Investments (TTM) -105.88